268
Views
28
CrossRef citations to date
0
Altmetric
Case Series

Cognitive effects of a dietary supplement made from extract of Bacopa monnieri, astaxanthin, phosphatidylserine, and vitamin E in subjects with mild cognitive impairment: a noncomparative, exploratory clinical study

, &
Pages 225-230 | Published online: 03 Feb 2014

References

  • PetersenRCSmithGEWaringSCIvnikRJTangalosEGKokmenEMild cognitive impairment: clinical characterization and outcomeArch Neurol199956330330810190820
  • PetersenRCMild cognitive impairment as a diagnostic entityJ Intern Med2004256318319415324362
  • MolanoJBoeveBFermanTMild cognitive impairment associated with limbic and neocortical Lewy body disease: a clinicopathological studyBrain2010133Pt 254055619889717
  • PetersenRCThomasRGGrundmanMAlzheimer’s Disease Cooperative Study GroupVitamin E and donepezil for the treatment of mild cognitive impairmentN Engl J Med2005352232379238815829527
  • BusseAHenselAGühneUAngermeyerMCRiedel-HellerSGMild cognitive impairment: long-term course of four clinical subtypesNeurology200667122176218517190940
  • Di CarloALamassaMBaldereschiMCIND and MCI in the Italian elderly: frequency, vascular risk factors, progression to dementiaNeurology200768221909191617536047
  • PlassmanBLLangaKMFisherGGPrevalence of cognitive impairment without dementia in the United StatesAnn Intern Med2008148642743418347351
  • ManlyJJTangMXSchupfNSternYVonsattelJPMayeuxRFrequency and course of mild cognitive impairment in a multiethnic communityAnn Neurol200863449450618300306
  • LopezOLJagustWJDeKoskySTPrevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 1Arch Neurol200360101385138914568808
  • PetersenRCRobertsROKnopmanDSPrevalence of mild cognitive impairment is higher in men. The Mayo Clinic Study of AgingNeurology2010751088989720820000
  • AndertonBHAging of the brainMech Aging Dev2002123781181711869738
  • FariasSTMungasDReedBRHarveyDDeCarliCProgression of mild cognitive impairment to dementia in clinic- vs community-based cohortsArch Neurol20096691151115719752306
  • GanguliMChangCCSnitzBESaxtonJAVanderbiltJLeeCWPrevalence of mild cognitive impairment by multiple classifications: The Monongahela-Youghiogheny Healthy Aging Team (MYHAT) projectAm J Geriatr Psychiatry201018867468320220597
  • BhattacharyaSKBhattacharyaAKumarAGhosalSAntioxidant activity of Bacopa monniera in rat frontal cortex, striatum and hippocampusPhytother Res200014317417910815010
  • ChowdhuriDKParmarDKakkarPShuklaRSethPKSrimalRCAntistress effects of bacosides of Bacopa monnieri: modulation of Hsp70 expression, superoxide dismutase and cytochrome P450 activity in rat brainPhytother Res200216763964512410544
  • RussoABorrelliFCampisiAAcquavivaRRacitiGVanellaANitric oxide-related toxicity in cultured astrocytes: effect of Bacopa monnieraLife Sci200373121517152612865091
  • RussoAIzzoAABorrelliFRenisMVanellaAFree radical scavenging capacity and protective effect of Bacopa monniera L. on DNA damagePhytother Res200317887087513680815
  • PaseMPKeanJSarrisJNealeCScholeyABStoughCThe cognitive-enhancing effects of Bacopa monnieri: a systematic review of randomized, controlled human clinical trialsJ Altern Complement Med201218764765222747190
  • McNultyHPByunJLockwoodSFJacobRFMasonRPDifferential effects of carotenoids on lipid peroxidation due to membrane interactions: X-ray diffraction analysisBiochim Biophys Acta20071768116717417070769
  • IwamotoTHosodaKHiranoRInhibition of low-density lipoprotein oxidation by astaxanthinJ Atheroscler Thromb20007421622211521685
  • ParkJSChyunJHKimYKLineLLChewBPAstaxanthin decreased oxidative stress and inflammation and enhanced immune response in humansNutr Metab (Lond)201071820205737
  • WolfAMAsohSHiranumaHAstaxanthin protects mitochondrial redox state and functional integrity against oxidative stressJ Nutr Biochem201021538138919423317
  • SatohATsujiSOkadaYPreliminary clinical evaluation of toxicity and efficacy of a new astaxanthin-rich Haematococcus pluvialis extractJ Clin Biochem Nutr200944328028419430618
  • AlbertsBJohnsonALewisJRaffMRobertsKWalterPMolecular Biology of the Cell4th edNew York, NYGarland Science2002
  • KiddPMPS (Phosphatidyl Serine), Nature’s Brain Booster2nd edSt George, UTTotal Health Communications2007
  • ToffanoGThe therapeutic value of phosphatidylserine effect in the aging brainHaninLAnsellGBLecithin: TechnologicalBiological and Therapeutic AspectsNew YorkPlenum Press1987137146
  • NunziMGMilanFGuidolinEZanottiAToffanoGTherapeutic properties of phosphatidylserine in the aging brainHaninIPepeuGPhospholipids: Biochemical, Pharmaceutical and Analytical ConsiderationsNew YorkPlenum Press1990213218
  • SamsonJCThe biological basis of phosphatidylserine pharmacologyClin. Trials J198724118
  • BorgheseCMGómezRARamírezOAPhosphatidylserine increases hippocampal synaptic efficacyBrain Res Bull19933166977008100181
  • ToffanoGBruniAPharmacological properties of phospholipid liposomesPharmacol Res Commun19801298298456108574
  • JoshiYBPraticòDVitamin E in aging, dementia, and Alzheimer’s diseaseBiofactors2012382909722422715
  • FolsteinMFFolsteinSEMcHughPR“Mini-mental state”. A practical method for grading the cognitive state of patients for the clinicianJ Psychiatr Res19751231891981202204
  • RosenWGMohsRCDavisKLA new rating scale for Alzheimer’s diseaseAm J Psychiatry198414111135613646496779
  • LibonDJSwensonRBaronskiEJSandsLPClock drawing as an assessment tool for dementiaArch Clin Neuropsychol19938540541514589710
  • RozziniLVicini ChiloviBBertolettiEThe importance of Alzheimer disease assessment scale-cognitive part in predicting progress for amnestic mild cognitive impairment to Alzheimer diseaseJ Geriatr Psychiatry Neurol200821426126719017783
  • CooperCLiRLyketsosCLivingstonGTreatment for mild cognitive impairment: systematic reviewBr J Psychiatry201320325526424085737